| Dec'19 | Dec'18 | Dec'17 | Dec'16 | |||
|---|---|---|---|---|---|---|
License revenue | ||||||
26,691 | - | - | - | |||
Operating costs and expenses: | ||||||
Cost of license revenue | ||||||
2,500 | - | - | - | |||
Research and development (includes related party expense (benefit) of $(242) and $94 for the three months ended March 31, 2020 and 2019, respectively) | ||||||
46,891 | 28,539 | 9,286 | 1,734 | |||
General and administrative (includes related party expense of $285 and $79 for the three months ended March 31, 2020 and 2019, respectively) | ||||||
17,751 | 9,240 | 2,730 | 651 | |||
Total operating expenses | ||||||
67,142 | 37,779 | 12,016 | 2,385 | |||
Loss from operations | ||||||
-40,451 | -37,779 | -12,016 | -2,385 | |||
Interest expense | ||||||
327 | 1,011 | - | - | |||
Other income (expense), net | ||||||
2,943 | -1,935 | 75 | -157 | |||
Net and comprehensive loss | ||||||
-37,835 | -40,725 | -11,941 | -2,542 | |||
Deemed dividend related to redemption feature embedded in Convertible Promissory Notes payable to stockholders | ||||||
6,500 | 6,523 | - | - | |||
Gain on extinguishment of Convertible Promissory Notes payable to stockholders | ||||||
- | 7,436 | - | - | |||
Net loss attributable to common stockholders | ||||||
-37,835 | -39,812 | -11,941 | -2,542 | |||
Net loss per share - basic and diluted | ||||||
-1.03 | -1.86 | -3.32 | -0.98 | |||
Weighted-average shares used in computing net loss per share - basic and diluted | ||||||
36,624 | 21,366 | 3,596 | 2,599 | |||